アネドニアは,核アクンベンスのMC4R媒介のシナプス適応を必要とします
Byung Kook Lim1, Kee Wui Huang, Brad A Grueter
1Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford, California 94305, USA.
Nature
|July 13, 2012
まとめ
慢性的なストレスは,脳内のシナプスを弱めることでうつ病を引き起こす. メラノコルチン4受容体の経路を遮断すると,ストレス誘発のアネドニアを予防し,うつ病の重要なメカニズムを明らかにします.
科学分野:
- 神経科学は神経科学である.
- 分子精神医学は分子精神医学である.
- 行動神経科学は,行動神経科学である.
背景:
- 慢性的なストレスは人間のうつ病の主要な危険因子であり,アンヘドニアや行動的絶望のような症状につながります.
- ストレス誘発性うつ病の根底にある脳回路における正確なシナプス適応は不明である.
- 動物モデルは,うつ病の神経基礎を理解するために不可欠です.
研究 の 目的:
- ネズミの慢性的なストレス誘発型うつ症状の基礎となるシナプスメカニズムを調査する.
- ストレス誘発性アンヘドニアにおけるメラノコルチン4受容体経路の役割を特定する.
- アンヘドニアを媒介する神経適応と行動的絶望を区別する.
主な方法:
- マウスにおける慢性ストレスパラダイムを利用した.
- 核アクンベンスの中等脊髄ニューロンにおけるシナプス可塑性を調べました.
- アンヘドニアと行動的絶望を含む行動的結果の測定.
- メラノコルチン4受容体シグナル伝達をin vivoでブロックする効果を調査した.
主要な成果:
- 慢性的なストレスは,D1ドーパミン受容体発現核アクンベンズニューロンにおける刺激シナプスの強さを低下させた.
- このシナプス衰弱は,メラノコルチン4受容体の活性化によって媒介された.
- これらの受容体媒介のシナプス変化を遮断することで,ストレス誘発性アネドニアは防げましたが,行動的絶望は防げませんでした.
- 異なる神経の適応が,異なるうつ症状の根底にある可能性が高い.
結論:
- ストレスによって引き起こされるアンヘドニアは,ニューロペプチドが駆動する,細胞タイプ特異的なシナプス変化に依存しています.
- メラノコルチン4受容体のシグナル伝達は,ストレス誘発性アネドニアの重要な媒介である.
- 異なる神経回路と適応が,うつ病の特徴的な症状を支配する可能性があります.
関連する概念動画
Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


